MARKET REPORT: Short circuit at Premier Farnell as shares crash after another profits warning
Activist investor GO Investment Partners is expected to increase the pressure on the Premier Farnell board to undergo an aggressive restructuring or merge with rival Electrocomponents.
Shares in electronics distributor Premier crashed 26.6p or 16 per cent to a five-year low of 140p on yet another profits warning.
GO recently increased its stake in the FTSE 250 company from 3.24 per cent to 4.11 per cent after first declaring a shareholding in May.
Premier warned that profits for the first half of 2015 would be a 10th below expectations as group sales per day had slowed significantly, particularly in its North American and UK markets, since its first quarter update in June. Group sales growth per day in the second quarter was now expected to be 1.2 per cent against the 5.4 per cent achieved in the first quarter.
Laurence Bain, chief executive, said that despite a number of initiatives to drive sales and expand profit margins, the company had been hit by a slowdown and a tougher trading environment. ‘We now expect adjusted operating profits in the second half to be at similar levels to those in the first half’, he said.
Peel Hunt’s analyst Henry Carver is of the opinion that a marriage with Electrocomponents (down 2.8p at 205.8p) may be the best solution if Premier can achieve it with minimum disruption.
Bumper earnings figures from some high-profile constituents helped the Footsie climb a further 75.72 points to 6631 and the FTSE 250 up 124.92 points to 17,512.81.
The early highlight was Barclays, 5p dearer at 284.6p, after the banking giant posted an impressive £3.14billion pre-tax profit for the first half of the year, up 25 per cent on 2014. News that it took a further big hit for mis-selling PPI and other customer compensation was ignored.
Later, drugs giant GlaxoSmithKline advanced 46p to 1374.5p after posting robust second-quarter sales of £5.9billion and confirming it is on track to achieve guidance for this year. New product momentum accelerated across all three businesses and the group is confident about the outlook for next year.
Wall Street followed Tuesday’s gain of 189 points with a further rise of 121.12 points as dealers digested a statement from the Federal Reserve that it would keep US rates at their historic low for at least another two months.
Generic drugs maker Hikma Pharmaceuticals rose 86p more for a two-day rise of 327p at 2407p as buyers continued to applaud its £1.7billion acquisition of Roxane Laboratories, the US generic drugs arm of Germany’s Boehringer Ingelheim, making it the sixth-largest firm by revenue in the US generics market.
Contract caterer Compass, 58p down at 1028p, gave shareholders indigestion after reporting a mixed third-quarter trading update with overall group revenue up by 5.1 per cent, slightly lower than the previous quarter. Lower volumes and margins in the group’s oil, gas and mining client base because of lower commodities prices led to a 10 basis points decline in overall group margins for the quarter.
Mouth-watering interims lifted Greggs 101p to a record 1285p. First-half profits jumped a better-than-expected 52 per cent to £25.6million on 6.45 per cent sales growth. Chief executive Roger Whiteside said he expected profits for the full-year to exceed analysts’ consensus forecasts, which stood at £67million before the update. Greggs announced a £20million special dividend in April and said yesterday it would pay an ordinary interim dividend of 7.4p, up from 6p last time.
Hedge fund Man Group jumped 11.4p to 162.4p in response to better-than-expected interim results. First-half profits rose 54 per cent to £104million and funds under management improved 8 per cent to £50.5billion.
Caretech, the provider of specialist social care services in the UK, rose 7.5p to 246.5p. It is buying Spark of Genius for £7.5million. It operates nine residential care and education services homes in Scotland with a total of 48 places, alongside 100 education places across three schools. Existing banking facilities, which were due to expire in January 2017, have been extended by two years to 2019. Broker WH Ireland lifted its target price to 345p from 330p.
The cold and flu outbreak in the UK earlier this year took its toll. Dignity, the UK’s biggest undertaker, conducted 39,500 funerals in the 26 weeks to June 26 – up from 33,800 a year earlier – as the overall number of deaths rose more than 13 per cent to 317,000. It lifted group pre-tax profits 44 per cent to £46.5million. Shares closed 66p higher at 2436p.
Small buyers chased Deltex Medical 0.25p higher to 6.12p after hearing the company has received approval from the US Food & Drug Aministration for the release of its paediatric probes for use with its CardioQ-QDM+ monitors. The business’s chief executive Ewan Phillips said that FDA approval ‘is excellent news for paediatricians in the USA who have, to date, had no safe or easy system to monitor sick children’s’ haemodynamics.’
In-line third-quarter figures helped Brewin Dolphin improve 3.8p to 311.1p.
- Deutsche Bank is a seller of Standard Chartered, 11.6p up at 982.2p, ahead of Wednesday’s interim figures. It will be the new chief executive Bill Winters’ first set of results. He recently outlined a new organisational structure, with eight regions under which the group reports consolidated to four regional businesses. The broker expects revenues to fall to £2.716billion in the second-quarter from £2.817billion in first.
Most watched Money videos
- German car giant BMW has released the X2 and it has gone electric!
- MailOnline asks Lexie Limitless 5 quick fire EV road trip questions
- Iconic Dodge Charger goes electric as company unveils its Daytona
- Dacia Spring is Britain's cheapest EV at under £15,000
- Skoda reveals Skoda Epiq as part of an all-electric car portfolio
- Mini unveil an electrified version of their popular Countryman
- MG unveils new MG3 - Britain's cheapest full-hybrid car
- Steve McQueen featured driving famous stunt car in 'The Hunter'
- BMW's Vision Neue Klasse X unveils its sports activity vehicle future
- Mail Online takes a tour of Gatwick's modern EV charging station
- 'Now even better': Nissan Qashqai gets a facelift for 2024 version
- The new Volkswagen Passat - a long range PHEV that's only available as an estate
- Unilever waters down targets on plastic packaging,...
- SHARE OF THE WEEK: Wall Street investors looking for...
- BUSINESS LIVE: Retail sales stagnate; 888 revenues beat...
- MARKET REPORT: Bruising week for FTSE amid Middle East fears
- Volvo's screen folly: New EX30 compact crossover lacks a...
- Retail sales ground to a halt last month as shoppers...
- Why is bitcoin halving this weekend? How the event could...
- 888 shares rise as William Hill owner posts...
- As record 2.8m sign off as long-term sick, work-shy UK...
- US and Europe are at odds and threat of a disastrous end...
- INVESTING EXPLAINED: What you need to know about cocoa...
- Mondi pulls out of potential bidding war to buy rival...
- Creators of key interest rate benchmark criticise courts...
- With cosmetics shares priced low, is now the time to...
- L'Oreal posts better than expected sales as demand for...
- Wall Street pins hopes on a set of upbeat results from...
- MARKET REPORT: Airlines soar as Easyjet eyes a record summer
- G7 fights for Ukraine cash as Russia's economy booms -...